Anticoagulation in Patients with Platelet Disorders.

Area of Science:

• Hematology
• Thrombosis and Hemostasis

Background:

• Platelet disorders present with bleeding symptoms but can also involve prothrombotic conditions.
• Anticoagulation in these patients is challenging due to increased bleeding risk.
• Existing evidence on anticoagulation for platelet disorders is reviewed.

Purpose of the Study:

• To provide an overview of anticoagulation in patients with acquired and inherited platelet disorders.
• To summarize risk assessment tools for bleeding and thrombosis.
• To describe a practical management approach for anticoagulation in these patients.

Main Methods:

• Literature review of evidence on anticoagulation in thrombocytopenia and platelet dysfunction.
• Summary of tools for evaluating bleeding and thrombotic risks.
• Description of a clinical management strategy.

Main Results:

• Patients with platelet disorders face a dual risk of bleeding and thrombosis.
• Risk assessment and balancing are crucial for safe anticoagulation.
• A structured approach is needed for managing anticoagulation in this population.

Conclusions:

• Anticoagulation in platelet disorders requires careful consideration of both bleeding and thrombotic risks.
• Utilizing risk assessment tools and a practical management approach is essential.
• Further research may be needed to optimize anticoagulation strategies.